| A Method for Gene Disruption That Allows Repeated Use of URA3 Selection in the Construction of Multiply Disrupted Yeast Strains E Alani, L Cao, N Kleckner Genetics 116 (4), 541-545, 1987 | 1132 | 1987 |
| A pathway for generation and processing of double-strand breaks during meiotic recombination in S. cerevisiae L Cao, E Alani, N Kleckner Cell 61 (6), 1089-1101, 1990 | 848 | 1990 |
| Temporal comparison of recombination and synaptonemal complex formation during meiosis in S. cerevisiae R Padmore, L Cao, N Kleckner Cell 66 (6), 1239-1256, 1991 | 539 | 1991 |
| Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F L Cao, B Faha, M Dembski, LH Tsai, E Harlow, N Dyson Nature 355 (6356), 176-179, 1992 | 453 | 1992 |
| Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity NS Azad, EM Posadas, VE Kwitkowski, SM Steinberg, L Jain, ... Journal of Clinical Oncology 26 (22), 3709-3714, 2008 | 383 | 2008 |
| Phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGFβ, in advanced solid tumors J Strauss, CR Heery, J Schlom, RA Madan, L Cao, Z Kang, E Lamping, ... Clinical Cancer Research 24 (6), 1287-1295, 2018 | 369 | 2018 |
| Safety and clinical activity of the programmed death-ligand 1 inhibitor durvalumab in combination with poly (ADP-ribose) polymerase inhibitor olaparib or vascular endothelial … JM Lee, A Cimino-Mathews, CJ Peer, A Zimmer, S Lipkowitz, ... Journal of Clinical Oncology 35 (19), 2193-2202, 2017 | 261 | 2017 |
| Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer L Cao, Y Yu, S Bilke, RL Walker, LH Mayeenuddin, DO Azorsa, F Yang, ... Cancer research 70 (16), 6497-6508, 2010 | 245 | 2010 |
| Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications R Harouaka, Z Kang, SY Zheng, L Cao Pharmacology & therapeutics 141 (2), 209-221, 2014 | 239 | 2014 |
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus H Chen, L Hutt-Fletcher, L Cao, SD Hayward Journal of virology 77 (7), 4139-4148, 2003 | 217 | 2003 |
| Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors G Giaccone, A Rajan, A Berman, RJ Kelly, E Szabo, A Lopez-Chavez, ... Journal of Clinical Oncology 29 (15), 2052-2059, 2011 | 214 | 2011 |
| A phase II clinical trial of sorafenib in androgen-independent prostate cancer WL Dahut, C Scripture, E Posadas, L Jain, JL Gulley, PM Arlen, JJ Wright, ... Clinical cancer research 14 (1), 209-214, 2008 | 213 | 2008 |
| DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1 IO Ng, Z Liang, L Cao, TK Lee Cancer research 60 (23), 6581-6584, 2000 | 175 | 2000 |
| Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody L Cao, Y Yu, I Darko, D Currier, LH Mayeenuddin, X Wan, C Khanna, ... Cancer research 68 (19), 8039-8048, 2008 | 174 | 2008 |
| Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)-and non-HIV-infected patients SSY Wong, KH Wong, WT Hui, SS Lee, JYC Lo, L Cao, KY Yuen Journal of clinical microbiology 39 (12), 4535-4540, 2001 | 149 | 2001 |
| Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. liang cao | 135* | |
| MP1 Encodes an Abundant and Highly Antigenic Cell Wall Mannoprotein in the Pathogenic Fungus Penicillium marneffei L Cao, C Chan, C Lee, S Sai-yin Wong, K Yuen Infection and immunity 66 (3), 966-973, 1998 | 133 | 1998 |
| Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1α expression in an AhR-independent fashion E Terzuoli, M Puppo, A Rapisarda, B Uranchimeg, L Cao, AM Burger, ... Cancer research 70 (17), 6837-6848, 2010 | 122 | 2010 |
| Crossover and noncrossover recombination during meiosis: timing and pathway relationships. A Storlazzi, L Xu, L Cao, N Kleckner Proceedings of the National Academy of Sciences 92 (18), 8512-8516, 1995 | 120 | 1995 |
| Detection of Specific Antibodies to an Antigenic Mannoprotein for Diagnosis of Penicillium marneffeiPenicilliosis L Cao, DL Chen, C Lee, CM Chan, KM Chan, N Vanittanakom, ... Journal of clinical microbiology 36 (10), 3028-3031, 1998 | 112 | 1998 |
James L. GulleyNational Cancer InstituteVerified email at mail.nih.gov
